US 10925902
Genetically engineered hematopoietic stem cells and uses thereof
granted A61KA61K2035/124A61K2039/505
Quick answer
US patent 10925902 (Genetically engineered hematopoietic stem cells and uses thereof) held by Vor Biopharma Inc. expires Mon Feb 18 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Vor Biopharma Inc.
- Grant date
- Tue Feb 23 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Feb 18 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 19
- CPC classes
- A61K, A61K2035/124, A61K2039/505, A61K2239/48, A61K35/28